Oncology Practice Management Issues

April 2017, Vol 7, No 4

Telemedicine: The Future Is Now

Meg Barbor, MPH

Oncology Practice Conference 2017

Orlando, FL—Telemedicine, or the remote diagnosis and treatment of patients by means of telecommunications technology, is now at the forefront of efficient healthcare delivery. This fundamental change in the delivery of healthcare focuses on bringing medicine to the patient rather than bringing the patient to medicine, said Richard J. Boxer, MD, FACS, Clinical Professor of Urology, David Geffen School of Medicine, University of California, Los Angeles, at ASCO’s first Oncology Practice Conference in March 2017. [ Read More ]

Operational and Cultural Changes in Oncology: Are You Paying Attention to Your Teams?

Gail Thompson

Cancer Center Business Summit

“Change creates angst: it creates pressures, it creates employee dissatisfaction, it creates environments that most medical practices aren’t used to participating in,” said Erich Mounce, MSHS, Chief Executive Officer, West Cancer Center, Memphis, TN, in his introduction to an intriguing panel discussion titled “Operational & Cultural Change” at the 2017 Cancer Center Business Summit (CCBS). [ Read More ]

Rapid Adoption of Novel Oncology Drugs Improves Overall Survival

Chase Doyle


Innovation takes time, especially when it comes to cancer research. However, delays in the adoption of novel oncology treatments can have a significant impact on patient health, reported Jason Shafrin, PhD, Director of Healthcare Quality and Value-Based Research Methods, and Senior Research Economist, Precision Health Economics, Los Angeles, CA, who presented the results of a geographic-based analysis of claims data at the 2017 Cancer Survivorship Symposium. [ Read More ]

Making the Transition from Volume to Value

Meg Barbor, MPH

Oncology Practice Conference 2017

Orlando, FL—Value-based care—the best care delivered at the lowest cost—is here to stay, said Karen K. Fields, MD, Medical Director, Clinical Pathways and Value-Based Cancer Care, Moffitt Cancer Center, Tampa, FL, at ASCO’s first Oncology Practice Conference in March 2017. But certain steps must be taken to ensure a smooth transition from fee-for-service to value-based care for institutions and for physicians, Dr Fields said. [ Read More ]

FDA News – April 2017

FDA Approvals, News & Updates

  • Keytruda Receives Accelerated Approval for Relapsed/Refractory Classical Hodgkin Lymphoma
  • Kisqali, a New CDK4/CDK6 Inhibitor, Approved as First-Line Therapy for HR-Positive, HER2-Negative Advanced Breast Cancer
  • Xermelo First Oral Treatment Approved for Carcinoid Syndrome Diarrhea in Patients with NETs
  • Revlimid Approved as Maintenance Therapy for Multiple Myeloma After Autologous Stem-Cell Transplantation
  • Opdivo Now Approved for Advanced or Metastatic Bladder Cancer
  • Imbruvica First Nonchemotherapy Drug Approved for Relapsed/Refractory Marginal Zone Lymphoma
  • Rubraca a New Treatment Option for Patients with Advanced Ovarian Cancer
[ Read More ]

Reducing Disparities in Survivorship Care

Chase Doyle


Surviving cancer is the start of a new journey for many individuals. Cancer survivors face a multitude of challenges, including the prevention of new and recurrent cancers; interventions for illnesses secondary to cancer and its treatment; concerns about employment, insurance, and disability; and coordination between specialists and primary care providers. These challenges are compounded by the need to ensure appropriate, culturally sensitive delivery of care to vulnerable patient populations, said Margaret Q. Rosenzweig, PhD, FNP-BC, AOCNP, FAAN, Professor of Acute and Tertiary Care, University of Pittsburgh School of Nursing, PA, at the 2017 Cancer Survivorship Symposium. [ Read More ]

Value-Based Care, MACRA, and the Oncology Care Model: Where Are We Headed?

Kashyap Patel, MD; Maharshi Patel, BS, MBA, COO

Oncology Care Model

The November 2016 presidential elections have cast a shadow in many minds about the future of the transition from the volume-driven, fee-for-service healthcare delivery model to the value-based care model. With the current promises of repealing and replacing the Affordable Care Act (ACA) of 2010, physicians and healthcare providers are left guessing as to what they will be expected to do, and where their future is heading. [ Read More ]

Racial Disparity, Age Play Role in Cervical Cancer Mortality Rates in the United States

Jessica Miller

Disparities in Cancer Care

Cervical cancer mortality rates are higher in the United States than previously estimated, according to a study published in the March 2017 issue of Cancer. This risk is particularly high in older black women, reported Anna L. Beavis, MD, Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, Johns Hopkins Medicine, Baltimore, MD, and colleagues, who corrected the mortality rates for hysterectomy, something that has not been done previously when estimating the mortality rates for cervical cancer. [ Read More ]

Wide Variation in Follow-Up Practices After Neuroendocrine Tumor Resection

Charles Bankhead

GI Cancers Symposium

San Francisco, CA—Follow-up for completely resected gastroenteropancreatic neuroendocrine tumors (GEP-NETs) varies widely, and the majority of clinicians ignore existing clinical guidelines, an international survey showed, reported Eva Segelov, MBBS (Hons 1), PhD, FRACP, Associate Professor of Medicine, St Vincent’s Clinic, Sydney, New South Wales, Australia, and colleagues, during a poster presentation at the 2017 Gastrointestinal Cancers Symposium. [ Read More ]